Life Science Outsourcing — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Life Science Outsourcing (LSO) is a well-established, private contract manufacturing and sterilization organization (CMO/CRO) catering to medical device and diagnostic companies. Its core value proposition is consolidating critical, regulated end-of-line services—assembly, kitting, sterilization, packaging validation, and fulfillment—under one roof to reduce vendor handoffs, accelerate time-to-market, and mitigate compliance risk for clients. With over 25 years in business, LSO leverages its FDA-registration and ISO certifications to support a diverse client base from startups to commercial OEMs, emphasizing flexibility, scalability, and deep regulatory expertise.

Drug DeliveryMedical Devices

Technology Platform

Integrated service infrastructure for medical device end-of-line processes, including FDA-registered/ISO 13485-certified cleanrooms, multi-modal sterilization (EtO, steam, gamma, ebeam) with ISO validation, and ISO 11607 packaging testing laboratories.

Opportunities

Growing demand for outsourced, integrated manufacturing and sterilization services from both cost-conscious OEMs and capital-efficient startups.

Increased regulatory complexity and sterilization capacity constraints drive need for expert, multi-modal partners like LSO.

Expansion into adjacent services like supply chain management and incubator support creates deeper client relationships and new revenue streams.

Risk Factors

Heavy reliance on maintaining FDA and ISO certifications; any significant quality failure could halt operations and damage reputation.

Exposure to regulatory and capacity pressures within the sterilization industry, particularly for Ethylene Oxide (EtO), could disrupt service delivery and client timelines.

Competitive Landscape

LSO competes with large, global contract manufacturing organizations (CMOs) offering broad services and specialized single-service providers (e.g., standalone sterilization or testing labs). Its key differentiator is the vertical integration of assembly, kitting, multi-modal sterilization, and packaging testing as a single-source, end-of-line partner, aiming to reduce client handoff risk and accelerate time-to-market.

More companies in Drug Delivery & Formulation →More companies in United States →